Fasenra 30 mg solution for injection in pre filled syringe
Product Information *
Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
UpdatedActive Ingredients :
This medicinal product is subject to additional monitoring.
*Additional information is available upon request
Legal Category:
Product subject to medical prescription which may not be renewed (A)
- Patient leaflets
- SPC
- Licence information
- Company info
- Doc history
- Educational Material-HCP
- Educational Material-Patient
What is a Patient Information leaflet and why is it useful?
A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.
20210326 Package Leaflet IE MT Fasenra PFS 30 mg Nijmegen Change RSP 21 0003
Last updated: 31/03/21